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Eleven cloned hybridomas which secrete antibodies to acetylcholine r ceptors from human muscle have 
been prepared. All of these monoclonal antibodies to have the same basic specificity as shown by 
competition for binding to the main immunogenic region on the receptor, but these antibodies differ in 
fine specificity as shown by reaction with denatured receptor subunits and interspecies cross-reaction. 
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1. INTRODUCTION 
Monoclonal antibodies (mAbs) to acetylcholine 
receptors (AChRs) from human skeletal muscles 
should proye interesting because these AChRs are 
the object of an antibody-mediated autoimmune 
response which causes the muscular weakness and 
fatigability characteristic of myasthenia gravis 
(MG) (reviewed in [l]). In addition, they might 
prove valuable for comparing the structure of 
human AChR with the better characterized struc- 
ture of AChR from the electric organ of Torpedo. 
Studies of the antigenic structure of AChRs 
from the electric organs of Torpedo californica [2] 
and Eiectrophorus electricus [3] using mAbs have 
revealed that a majority of the antibodies made by 
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rats to intact AChRs from these species are 
directed at the main immunogenic region (MIR). 
This is demonstrated by the ability of a single mAb 
bound to the MIR to prevent the binding of a large 
fraction of serum anti-AChR antibodies to AChR. 
AChRs have the subunit structure a$y& (reviewed 
in [4]). The MIRs are distinct from the acetyl- 
choline binding sites, but are also located on the 
extracellular surface of a subunits [5]. The MIR is 
relatively conformation dependent [2, 31 and 
relatively trypsin resistant [6]. mAbs to the MIR 
can crosslink AChRs and cause AChR loss from 
cells by antigenic modulation [7]. mAbs to the 
MIR can also passively transfer the complement- 
dependent acute form of experimental autoim- 
mune myasthenia gravis [2]. mAbs to the MIR can 
inhibit the binding of a majority of the anti-AChR 
antibodies in MG patients, while mAbs specific for 
the ,& and y-subunits of AChRs can only inhibit 
the binding of a smaller fraction [8]. Antisera from 
rats immunized with human AChR in competition 
experiments also appear to be preferentially 
directed at the MIR [8]. 
Here, we report the preparation of 11 mAbs 
from rats immunized with human AChR, all of 
which are directed at the MIR. 
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2. EXPERIMENTAL 
AChRs were purified by affinity chromatogra- 
phy on cobra toxin-agarose [9]. Hybridomas 
secreting mAbs to human AChRs were prepared in 
the same way as we prepared hybridomas to other 
AChRs in [2, 31. Lewis rats were injected with 2 pug 
AChR emulsified in 200 pl complete Freund’s ad- 
juvant on day 0, 1 pg in adjuvant on day 32, and 
sacrificed on day 36. Spleen cells (1 x lo*) were 
fused with non-secreting mouse myeloma cells (3 
x 10’ of S194/5.XXO.BD.l) using 50% poly- 
ethylene glycol 1500 by the basic technique in [lo]. 
Culture supernatants were screened by radioim- 
munoassay using r2’hBGT labeled AChR as anti- 
gen [9].. Immunoglobulin fractions of the media 
from cloned hybrids were isolated and concen- 
tratecd via ammonium sulfate precipitation. 
Immunoglobulin subclasses were determined by 
radial immunodiffusion using typing antisera from 
Miles. Binding of mAbs to S. aureus (Pansorbin 
from Calbiochem-Behring) was tested by radioim- 
munoassay [2,3]. 
Binding to the MIR was determined by competi- 
tion with mAb 35 (a rat anti-MIR mAb raised 
against AChRs from Electrophorus electricus) [3]. 
Binding to ‘251-labeled AChR subunits dissociated 
with SDS was measured by immune precipitation, 
electrophoresis, and autoradiography as in [2, 31. 
Antibody titers against human, bovine and 
Torpedo AChRs were measured by immune 
precipitation using ‘251~BT-labeled AChRs as 
antigen and titers were expressed in moles of 
‘25~BGT binding sites bound per liter [9]. 
3. RESULTS AND DISCUSSION 
Eleven stable hybridoma lines producing mAbs 
to human skeletal muscle AChR were made by fus- 
ing spleen cells of rats immunized with purified 
AChR with mouse myeloma cells. 
The properties of the constant regions of these 
mAbs were studied (table 1). Both IgM and several 
subclasses of IgG antibodies were obtained. As ex- 
pected of rat immunoglobulins, many did not bind 
well to fixed S. aureus cells. 
More importantly, the properties of the variable 
regions of these mAbs were also studied (table 1). 
By competitive binding studies with mAb 35, all of 
the mAbs to human AChR were directed at the 
MIR. All of the mAbs were also mutually com- 
petitive for binding to human AChR. One of the 
Table 1 
Properties of rat mAbs to human muscle AChR 
mAba 
189 
190 
192 
195 
196 
197 
198 
202 
203 
204 
207 
Constant region properties 
Immunoglobulin Binding to 
class Staph. aureus 
? 
IgCi2b - 
IgG2b - 
IgGl + 
IgM + 
IgM - 
IgG2a - 
IgGl + 
IgG2a + 
? + 
IgG2a - 
Variable region properties 
Binding site Species specificity % crossreactionb 
specificity 
Bovine AChR Torpedo AChR 
MIR 100 0 
MIR 37 0 
MIR 68 0 
MIR, (Y 98 0 
MIR 0 0 
MIR 0 0 
MIR, a 100 100 
MIR, cy 93 0 
MIR, LY 100 100 
MIR, cy 100 0 
MIR. cy 100 0 
%nAb 189 reacted with none of the isotyping sera used, while mAb 204 reacted with all of the isotyping sera used 
bPercent crossreaction is calculated by dividing the titer against the antigen (in moles of ‘%YBGT binding sites of 
AChR bound/liter of antibody solution) by the titer against human AChR 
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mAbs (198) was tested on sucrose gradients with 
‘251aGBT-labeled bovine AChR. As in the case of 
mAbs to the MIR on AChR from Torpedo and 
Electrophorus [7], mAb 198 could crosslink AChR 
monomers and bind 2 mAbs/AChR in mAb excess 
(not shown). Six of these mAbs crossreacted with 
12sI-labeled, SDS denatured (Y subunits of AChR 
from bovine muscle. Two of these mAbs (198 and 
203) also crossreacted with ‘251-labeled, SDS- 
denatured a-subunits of AChR from Torpedo 
electric organ. These results are consistent with 
those obtained with other anti-MIR mAbs in show- 
ing that the MIR is a conformation-dependent an- 
tigenic determination, but that some crossreaction 
at lower affinity is retained with denatured (Y- 
subunits. 
Even though it was expected that immunization 
with nondenatured AChR should produce a 
disproportionate response to the MIR, it is striking 
that all of the mAbs are of this specificity. One 
contributing factor is probably that the amputated 
human leg muscle is subject to autolysis and the 
AChR purified from human leg muscle lacked in- 
tact 8, y and S subunits. Because the MIR is 
relatively resistent to proteolysis [6], by contrast 
with most other antigenic determinants on the 
AChR, the effect of this proteolysis is probably to 
destroy many other potentially immunogenic sites. 
Most of these mAbs (9/l 1) crossreact very well 
with bovine AChR, while only two crossreact well 
with Torpedo AChR (table 1). These results are 
consistent with the interspecies crossreactivity of 
anti-AChR sera and reflect the high crossreactivity 
of other anti-MIR mAbs, apparently due to the 
conserved structure of this antigenic determinant 
[2, 3, 81. The observation that all of these mAbs 
are mutually competitive for binding to the same 
structure on AChR, yet that some are highly 
species pecific (e.g., 196 and 197) while others are 
not (e.g., 198 and 203), probably reflects the range 
of different anti-body idiotypes capable of binding 
to the MIR. 
These mAbs should prove valuable in further 
studies of MG and of the AChR molecule. For ex- 
ample, mAb 203 and other anti-MIR mAbs raised 
against AChRs from Torpedo, Electrophorus, and 
cattle are capable of specifically labeling neurons 
in the lateral spiriform nucleus of chicken brain 
[ill. 
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